
Fund open for subscription

Marigold Maturation Fund K/S
The Marigold Maturation Fund seeks to invest capital in early-stage and promising biotech companies to generate attractive returns, regardless of economic cycles. To ensure this, the biotech projects that form the basis of potential biotech companies undergo a comprehensive selection process, due diligence, and maturation, thereby minimizing risk. MGI Investment Management aims to increase the likelihood of success by identifying potential challenges prior to making an investment.


Marigold Maturation Fund








Medical Biotechnology
Number of portfolio companies: 4-8
Hard Cap: DKK 600.000.000
No financial leverage in the fund or the companies
Expected return IRR: 20-25%
Distributions expected to begin in 3-5 years
Fund duration: 10 years
Minimum investment: DKK 750.000

Are you interested in expanding your investment portfolio? Would you like to learn more about investment opportunities in biotechnology?
Request investor material here
MGI Investment Management ApS
Agern Allé 24
2970 Hørsholm
CVR 43867970
AIFM
MGI Investment Management ApS is registered with the Financial Supervisory Authority as a manager of alternative investment funds (AIFM)
FTID: 23321
Auditor
Sønderup I/S
Authorized auditor
CVR 31824559
Terms and conditions
© Marigold Innovation 2025